Health Now

Immune therapy drugs show promise in treating esophageal cancer

Tawnya Panizzi
Slide 1
Louis B. Ruediger | TribLive
Gary Hines of Harrison is pictured in his kitchen. Hines was diagnosed with esophageal cancer during the covid-19 pandemic and spent the majority of time battling the cancer with the help of his wife, Anita, at home. After participating in a clinical trial, Hines is in remission.
Slide 2
Courtesy of Gary Hines
Gary Hines of Harrison celebrates ringing the cancer-free bell after battling esophageal cancer at AHN.
Slide 3
Louis B. Ruediger | TribLive
Gary Hines of Harrison is pictured in his home. Hines was diagnosed with is esophageal cancer in 2020 and is in remission. He’s enjoyed getting back to his passion of hunting whitetail deer.
Slide 4
Louis B. Ruediger | TribLive
Gary and Anita Hines of Harrison.
Slide 5
Courtesy of AHN
Dr. Kirsten Newhams is associate program director for the Minimally Invasive Foregut and Advanced Endoscopy Fellowship at the Esophageal Institute at AHN.
Slide 6
Courtesy of AHN
Dr. Ali Zaidi is medical director of aerodigestive research at the AHN Cancer Institute.

Share this post: